@misc{a4ebe6a944ee40a0b3e9e8b8dc87cf59,
title = "Elimination half-life may explain the relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1",
keywords = "Antiviral Agents, therapeutic use, Genotype, Hepacivirus, genetics, Hepatitis C, drug therapy, Humans, Oligopeptides, therapeuti/c use, Proline, analogs /\&/ derivatives, Antiviral Agents, therapeutic use, Genotype, Hepacivirus, genetics, Hepatitis C, drug therapy, Humans, Oligopeptides, therapeuti/c use, Proline, analogs /\&/ derivatives",
author = "Andrea CALCAGNO and Lucio BOGLIONE and FG, \{De Rosa\} and Di, \{Perri G\} and S Bonora",
year = "2013",
doi = "10.1093/cid/cit087",
language = "English",
type = "Other",
}
